...
首页> 外文期刊>Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry >Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat.
【24h】

Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat.

机译:可乐定和羟甲唑啉诱导的大鼠胃动力抑制的突触前和突触后机制。

获取原文
获取原文并翻译 | 示例
           

摘要

The inhibitory effect of clonidine (non-selective alpha2-adrenoceptor agonist) and oxymetazoline (alpha2A-adrenoceptor selective agonist) was compared on basal and stimulated gastric motor activity (gastric tone and contractions) using the balloon method in the rat. It was shown that oxymetazoline (0.2-1.7 micromol/kg, i.v.) decreased the basal motility, while clonidine (1.9-3.8 micromol/kg, i.v.) failed to affect it. When motility was stimulated centrally by insulin (5 IU/rat, i.v.), both clonidine (1.9-3.8 micromol/kg, i.v.) and oxymetazoline (0.1-3.4 micromol/kg, i.v.) inhibited the gastric motor activity. However, while the effect of clonidine was antagonized by the non-selective alpha2-adrenoceptor antagonist yohimbine (5 micromol/kg, i.v.) and the alpha2A-adrenoceptor selective antagonist BRL 44408 (3 micromol/kg, i.v.), the effect of oxymetazoline was only partially affected. Prazosin (alpha1- and alpha2B-adrenoceptor antagonist, 0.07-0.28 micromol/kg, i.v.) also failed to reverse the effect of oxymetazoline. Furthermore, when gastric motility was stimulated peripherally by activation of postsynaptic cholinergic muscarinic receptors by the combination of carbachol (0.14 micromol/kg, i.v.) and hexamethonium (37 micromol/kg, i.v.), clonidine (3.8 micromol/kg, i.v.) failed to affect the increased motor activity, however, oxymetazoline (0.8-3.4 micromol/kg, i.v.) exerted a pronounced inhibition. These results suggest that different mechanisms may be involved in the inhibitory effect of clonidine and oxymetazoline; while clonidine reduces the gastric motility by activation of presynaptic alpha2-adrenoceptors, postsynaptic component in the effect of oxymetazoline has also been raised.
机译:使用气球法比较了可乐定(非选择性α2-肾上腺素受体激动剂)和羟甲唑啉(α2A-肾上腺素受体激动剂)对大鼠基础和刺激胃运动活动(胃肌张力和收缩)的抑制作用。结果表明,羟甲唑啉(0.2-1.7 micromol / kg,静脉内)降低了基础运动能力,而可乐定(1.9-3.8 micromol / kg,静脉内)对此没有影响。当胰岛素(5 IU /大鼠,静脉)集中刺激运动时,可乐定(1.9-3.8 micromol / kg,静脉)和​​羟甲唑啉(0.1-3.4 micromol / kg,静脉)均会抑制胃运动。然而,尽管可乐定的作用被非选择性的α2-肾上腺素受体拮抗剂育亨宾(5μmol/ kg,iv)和α2A-肾上腺素选择性拮抗剂BRL 44408(3μmol/ kg,iv)所拮抗,但羟甲唑啉的作用却是仅部分受影响。吡唑嗪(α1-和α2B-肾上腺素受体拮抗剂,0.07-0.28μmol/ kg,静脉内)也未能逆转羟甲唑啉的作用。此外,当通过卡巴胆碱(0.14 micromol / kg,iv)和六甲铵(37 micromol / kg,iv)的结合通过突触后胆碱能毒蕈碱受体的活化来刺激胃蠕动时,可乐定(3.8 micromol / kg,iv)未能发挥作用羟甲唑啉(0.8-3.4 micromol / kg,iv)具有明显的抑制作用。这些结果表明可乐定和羟甲唑啉的抑制作用可能涉及不同的机制。尽管可乐定通过激活突触前的α2-肾上腺素能受体来降低胃动力,但在羟甲唑啉中,突触后的成分也有所提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号